
Exemestane: Uses, Dosage, Side Effects, Warnings - Drugs.com
2024年8月23日 · Exemestane (brand name Aromasin) is an aromatase inhibitor used to lower estrogen levels in women past menopause with early or advanced hormone-sensitive breast …
Exemestane (Aromasin) - Uses, Side Effects, and More - WebMD
2024年8月19日 · Exemestane belongs to a class of medicines called aromatase inhibitors. It works by blocking an enzyme called aromatase that helps produce estrogen in the body. By …
Exemestane (oral route) - Mayo Clinic
Exemestane is used to treat early and advanced breast cancer in women who have already stopped menstruating (postmenopausal). It is usually used in women who have already …
Exemestane - Wikipedia
Exemestane, sold under the brand name Aromasin among others, is a medication used to treat breast cancer. It is a member of the class of antiestrogens known as aromatase inhibitors. …
Exemestane (Aromasin®): Uses & Side Effects - Cleveland Clinic
Exemestane is a medication that treats some types of breast cancer by blocking production of the hormone estrogen. Certain types of cancer depend on estrogen to grow. This medication …
依西美坦 - 百度百科
依西美坦,化学名称为6-亚甲基雄甾-1,4-二烯-3,17-二酮,是一种有机化合物,化学式为C20H24O2,为白色至淡黄色结晶性粉末,溶于甲醇,不溶于水,是一种抗肿瘤药,临床上适 …
Exemestane - Chemocare
EXEMESTANE (ex e MES tane) treats breast cancer. It works by decreasing the amount of estrogen hormone your body makes, which slows or stops breast cancer cells from spreading …
Exemestane: MedlinePlus Drug Information
Exemestane is used to treat early breast cancer in women who have experienced menopause ('change of life'; end of monthly menstrual periods) and who have already been treated with a …
DailyMed - EXEMESTANE tablet
Exemestane tablets, USP are used in women who are past menopause for the treatment of: Early breast cancer (cancer ...
Aromasin (exemestane) dosing, indications, interactions, adverse ...
ASCO and NCCN guidelines suggest exemestane as an alternative to tamoxifen or raloxifene to prevent invasive breast cancer in high-risk women. 25 mg PO qDay for 5 years. …